Search by Drug Name or NDC

    NDC 68788-7175-09 Desvenlafaxine 100 mg/1 Details

    Desvenlafaxine 100 mg/1

    Desvenlafaxine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is DESVENLAFAXINE SUCCINATE.

    Product Information

    NDC 68788-7175
    Product ID 68788-7175_acdff26b-e48e-4f25-a5dc-b0b21c14641c
    Associated GPIs 58180020207540
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Desvenlafaxine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Desvenlafaxine Succinate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name DESVENLAFAXINE SUCCINATE
    Labeler Name Preferred Pharmaceuticals Inc.
    Pharmaceutical Class Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204003
    Listing Certified Through 2024-12-31

    Package

    NDC 68788-7175-09 (68788717509)

    NDC Package Code 68788-7175-9
    Billing NDC 68788717509
    Package 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7175-9)
    Marketing Start Date 2018-06-11
    NDC Exclude Flag N
    Pricing Information N/A